Retraction notices

The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia

Type

Retraction

Notice date

7/19/2023 0:00

Journal

Contrast Media & Molecular Imaging

Publisher

Hindawi

Notice DOI

10.1155/2023/9783232

Original paper DOI

10.1155/2022/2256690

Reasons

• Concerns/Issues about Data
• Concerns/Issues about Results and/or Conclusions
• Concerns/Issues about Referencing/Attributions
• Concerns/Issues about Peer Review
• Informed/Patient Consent - None/Withdrawn
• Investigation by Journal/Publisher
• Investigation by Third Party
• Lack of IRB/IACUC Approval and/or Compliance
• Paper Mill
• Computer-Aided Content or Computer-Generated Content
• Unreliable Results and/or Conclusions

Matching venue names

Name match only, not an authoritative journal identifier.

• Contrast Media & Molecular Imaging